IceCure Medical (ICCM) Net Income (2020 - 2026)

IceCure Medical (ICCM) has reported Net Income for 7 consecutive years, with -$4.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Net Income fell 33.8% year-over-year to -$4.5 million in Q2 2026; TTM through Jun 2026 was -$16.9 million, a 8.34% decrease from a year earlier, with the FY2025 full-year figure at -$15.1 million, up 1.7% from the prior year.
• Net Income was -$4.5 million for Q2 2026 at IceCure Medical, down from -$4.3 million in the prior quarter.
• Over five years, Net Income peaked at $30.0 million in Q4 2022 and troughed at -$4.5 million in Q2 2022.
• A 5-year average of -$417777.8 and a median of -$3.9 million in 2023 frame the typical range for Net Income.
• The widest YoY moves for Net Income: up 80.42% in 2022, down 224.36% in 2022.
• Over 5 years, Net Income stood at $30.0 million in 2022, then retreated by 12.32% to $26.3 million in 2023, then tumbled by 117.02% to -$4.5 million in 2024, then rose by 5.2% to -$4.2 million in 2025, then slipped by 6.01% to -$4.5 million in 2026.
• The last three Net Income figures came in at -$4.5 million (Q2 2026), -$4.3 million (Q1 2026), and -$4.2 million (Q4 2025), per Business Quant data.